All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityEquity IPOs

Synlab to shrink deal and price at bottom


Europe’s turbulent IPO market has taken its toll on the listing of Synlab, the German laboratory technology company, with the sellers deciding to shrink the size of the transaction after investors refused to budge from the bottom of the price range.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree